| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:MDM2/XIAP-IN-3
CAS:2925583-17-9
Package:100mg/RMB 17500;50mg/RMB 13800;25mg/RMB 10600
|
MDM2/XIAP-IN-3 manufacturers
- MDM2/XIAP-IN-3
-
- $2500.00 / 100mg
-
2025-10-27
- CAS:2925583-17-9
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | MDM2/XIAP-IN-3 Basic information |
| Product Name: | MDM2/XIAP-IN-3 | | Synonyms: | MDM2/XIAP-IN-3;Furo[3,2-c]quinoline-8-sulfonamide, N-(3-acetylphenyl)-2,3,3a,4,5,9b-hexahydro-4-[4-(2-methyl-1-oxopropyl)phenyl]- | | CAS: | 2925583-17-9 | | MF: | C29H30N2O5S | | MW: | 518.63 | | EINECS: | | | Product Categories: | | | Mol File: | 2925583-17-9.mol |  |
| | MDM2/XIAP-IN-3 Chemical Properties |
| Boiling point | 708.224±70.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.273±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 7.737±0.40(predicted) |
| | MDM2/XIAP-IN-3 Usage And Synthesis |
| Uses | MDM2/XIAP-IN-3 (compound 3e) is a dual MDM2/XIAP inhibitor. MDM2/XIAP-IN-3 reduces MDM2 and XIAP protein levels and increases p53 expression, thereby inhibiting cancer cell growth and causing cell death[1]. | | References | [1] Albadari N, et al. Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold. Eur J Med Chem. 2023 Jul 5;255:115423. DOI:10.1016/j.ejmech.2023.115423 |
| | MDM2/XIAP-IN-3 Preparation Products And Raw materials |
|